Therapy for Fibrotic Diseases: Nearing the Starting Line

Cites (209)

Items 201–209 of 209

1. Gene expression profiling of the donor kidney at the time of transplantation predicts clinical outcomes 2 years after transplantation
   Gabor Bodonyi-Kovacs, Prabhakar Putheti, Miguel Marino, Yingyos Avihingsanon, Marc E. Uknis, Anthony P. Monaco, Terry B. Strom, Martha Pavlakis · 2010 · Human Immunology
2. Predicting cirrhosis and clinical outcomes in patients with advanced chronic hepatitis C with a panel of genetic markers (CRS7)
   Teresa M. Curto, ROBERT J. LAGIER, Anna Suk-Fong Lok, James E. Everhart, Charles M. Rowland, John J. Sninsky · 2011 · Pharmacogenetics and Genomics
3. Antifibrotic Treatment and Other New Strategies for Improving Renal Outcomes
   Anna Vachaparampil Mathew, Robyn A. Cunard, Kumar Sharma · 2011 · Contributions to nephrology
4. Idiopathic pulmonary fibrosis: Treatment update
   Oisin J. O’Connell, Marcus Peter Kennedy, Michael Thomas Henry · 2011 · Advances in Therapy
5. Anti-inflammatory effect by lentiviral-mediated overexpression of IL-10 or IL-1 receptor antagonist in rat glial cells and macrophages
   Miriam E. van Strien, D Mercier, Benjamin Drukarch, John J. P. Brevé, Stephen Poole, Rob Binnekade, John G. J. M. Bol, Bas Blits, Joost Verhaagen, A.-M. van Dam · 2010 · Gene Therapy
6. Endothelial Progenitor Cells: Hope Beyond Controversy
   Eddy Pasquier, Sérgio Dias · 2010 · Current Cancer Drug Targets
7. Therapy for hepatic fibrosis: Revisiting the preclinical models
   D. Montgomery Bissell · 2011 · Clinics and Research in Hepatology and Gastroenterology
8. Ontogeny of Lagerhans Cells and Graft Versus Host Disease
   Miriam Mérad · 2005 · Advances in experimental medicine and biology
9. Pericyte-Like Cells And Resident Fibroblasts Are Sources Of Myofibroblasts In Acute Lung Injury
   Chi F. Hung, Geoffrey R. Linn, Jeremy S. Duffield, Lynn M. Schnapp · 2012